The Scientist

» FDA and developmental biology

Most Recent

image: Sex Differences in the Brain

Sex Differences in the Brain

By | October 1, 2015

How male and female brains diverge is a hotly debated topic, but the study of model organisms points to differences that cannot be ignored.

27 Comments

image: FDA Warns Liquid Biopsy Maker

FDA Warns Liquid Biopsy Maker

By | September 25, 2015

The agency fires off a letter to Pathway Genomics, telling the company that its new cancer detection test could harm the public and is not validated by science.

0 Comments

image: Duke Cardiologist Tapped to Lead FDA

Duke Cardiologist Tapped to Lead FDA

By | September 17, 2015

The Obama administration has nominated Robert Califf, a researcher who conducted large clinical trials, as the next person to head the country’s drug approval agency.

0 Comments

image: TS Picks: September 8, 2015

TS Picks: September 8, 2015

By | September 8, 2015

Pharma edition

0 Comments

image: The Sounds of Silence

The Sounds of Silence

By | September 1, 2015

Science-based tinnitus therapeutics are finally coming into their own.

3 Comments

image: Whaling Specimens, 1930s

Whaling Specimens, 1930s

By | September 1, 2015

Fetal specimens collected by commercial whalers offer insights into how whales may have evolved their specialized hearing organs.

0 Comments

image: Q&A: Placental Ponderings

Q&A: Placental Ponderings

By | August 27, 2015

Biologist Christopher Coe answers readers’ questions about the prescient organ.

0 Comments

image: Valeant Scoops Sprout for $1 Billion

Valeant Scoops Sprout for $1 Billion

By | August 24, 2015

The Canadian pharmaceutical firm is buying the American drugmaker behind the newly approved “female Viagra.”

0 Comments

image: “Female Viagra” Approved

“Female Viagra” Approved

By | August 19, 2015

The US Food and Drug Administration OKs the first drug for female sexual dysfunction.

0 Comments

image: Report: Impact of Biomedical Research Slipping

Report: Impact of Biomedical Research Slipping

By | August 18, 2015

Despite dramatic increases in publications, the last 50 years have seen relatively little return on investment for US public health, a study suggests.

15 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech